Healthtech Startups

Biointaxis is an academic biotech spin-off developing a gene therapy to restore the function of a defective protein in patients with Friedreich's ataxia, a rare inherited neurodegenerative disease. The company handles early-stage R&D, pre-clinical, and early clinical (Phase I/II) development, aiming to license production and distribution rights to pharmaceutical partners.

1 investor

1 investor

Unable to determine company business from page content. The page appears to be an investor relations contact page in Chinese for a company with headquarters in Shenzhen.

1 investor

BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.

1 investor

Groupe Biolam operates a network of medical biology laboratories that provide diagnostic analyses and support patients in their care pathway. It runs 28 labs in Hauts-de-France, 13 in Normandy, and 10 in Île-de-France.

1 investor

BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.

1 investor

Biolectrics develops ORAFLOW, a periodontal therapy product for oral/dental care.

1 investor

BioLife Solutions develops biopreservation media, cryopreservation tools, storage systems, and closed-system cell processing solutions for cell and gene therapy manufacturing. It serves bioprocess engineers, therapy developers, and contract development and manufacturing organizations (CDMOs), with regulatory support for GMP, FDA, and EMA compliance.

1 investor

Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.

1 investor

BioLink is a biotechnology company that develops and manufactures process equipment and consumables for life science applications, including recombinant protein drugs, vaccines, antibody drugs, cell therapy, and gene therapy production. The company supplies upstream cell culture, disposable storage and downstream chromatography, filtration, and hydration products along with process development services.

1 investor

Biolyst supplies tools, products, and consulting services to clinicians and research scientists advancing discovery in the life sciences. The company specializes in supporting laboratory and clinical workflows through comprehensive product portfolios and strategic partnerships with healthcare and research institutions.

1 investor

BioMarin is a biotechnology company that develops medicines derived from genetic discoveries to treat serious and rare diseases. Founded in 1997, it markets nine commercial therapies and maintains a clinical and preclinical drug development pipeline.

1 investor

Biome Resources develops Kronobiotic, a supplement designed to balance intestinal microbiota. The company offers health-focused products sold through online channels.

1 investor

Provides biomedical testing services focused on gut microbiome analysis combined with personalized probiotic treatments to address common urban health issues. The company bases its approach on genetic testing and proprietary probiotic formulations tailored to individual needs.

1 investor

Biomine Health is South Africa's microbiome testing and treatment company, providing personalized health insights based on microbiome analysis to help people understand and optimize their gut health. The company serves individuals seeking proactive health management through microbiome-based diagnostics and treatments.

1 investor

Bioneer develops molecular biology products including magnetic bead-based mRNA purification using Oligo(dT), multiplex target analysis, and cell-free protein synthesis and purification systems. Its offerings serve life science research and laboratory workflows in the biotechnology sector.

1 investor

Bioness Medical develops neuromodulation systems, robotic systems, and software-based therapy programs for patients with central nervous system disorders and orthopedic injuries. The company's offerings aim to improve patient outcomes and enhance efficiency for healthcare providers.

1 investor

Bionote develops animal-health and diagnostic products, including rapid immunodiagnostic tests, fluorescent and enzyme immunoassays, molecular diagnostics, and vaccines. It operates in the veterinary/biotech diagnostics industry.

1 investor

Bionova Medical develops Foundation DRS Solo, a biodegradable, collagen-free chitosan-glycosaminoglycan dermal regeneration scaffold for advanced wound care. The device is intended to promote healing of full and partial thickness wounds, ulcers, burns, surgical wounds, and other skin injuries.

1 investor

Bionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.

1 investor

Bionure Investment is a company based in Barcelona focused on developing solutions for neurodegenerative diseases affecting patients worldwide. The organization operates in the biotech and digital health sectors.

1 investor

Biopharm is a pharmaceutical company founded in 1992 that manufactures and distributes medications and medical devices in Algeria. The company serves the Algerian healthcare market and is a major player in the country's pharmaceutical industry.

1 investor

Bioprex Medical develops antibacterial coatings for medical devices to prevent infections by inhibiting biofilm formation on device surfaces. The company serves healthcare providers and medical device manufacturers seeking to reduce device-associated infection risk.

1 investor

BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.

1 investor